Akebia Therapeutics
AKBA
#7494
Rank
โ‚น36.71 B
Marketcap
โ‚น138.35
Share price
-3.14%
Change (1 day)
-19.12%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚น36.71 Billion

As of December 2025 Akebia Therapeutics has a market cap of โ‚น36.71 Billion. This makes Akebia Therapeutics the world's 7494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น36.71 B0.59%
2024โ‚น36.49 B87.68%
2023โ‚น19.44 B121.4%
2022โ‚น8.78 B-70.16%
2021โ‚น29.43 B-0.56%
2020โ‚น29.59 B-46.03%
2019โ‚น54.83 B21.33%
2018โ‚น45.19 B0.71%
2017โ‚น44.88 B65.54%
2016โ‚น27.11 B2.98%
2015โ‚น26.32 B75.19%
2014โ‚น15.02 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Akebia Therapeutics was reported to be:

โ‚น36.71 Billion
by Nasdaq info icon info icon
โ‚น36.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น15.958 T 43,368.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น22.781 T 61,952.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚น43.706 T 118,948.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น103.97 B 183.22%๐Ÿ‡บ๐Ÿ‡ธ USA